SmallCaps
ASX:TLXPharmaceuticals, Biotechnology & Life SciencesBiotechnology

Telix Pharmaceuticals Ltd

$15.810
+$1.250 (+8.59%)
Day Range
$14.670 – $16.060
52 Week Range
$8.260 – $25.870
Volume
2.39M
Avg Volume (10D)
2.53M
Market Cap
$5.37B

Price Chart

OHLC · volume · moving averages

$15.810+$3.920 (+32.97%)over 6M
Hi$16.060Lo$8.260
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today's trading range

Open
$14.670
Previous Close
$14.560
Day High
$16.060
Day Low
$14.670
52 Week High
$25.870
52 Week Low
$8.260

Valuation

Fundamental multiples

Market Cap
5.37B
Shares Outstanding
339.38M
Price to Book
8.13

Trading Activity

Volume & order book

Volume
2.39M
Value Traded
37.16M
Bid
$15.800 × 272
Ask
$15.810 × 265

Performance

Returns across timeframes

1 Day
-2.00%
5 Day
3.05%
13 Week
11.02%
52 Week
-42.98%
YTD
26.88%

Technical Indicators

Momentum & moving averages

RSI (14)
71.79
50-Day SMA
$14.227
200-Day SMA
$13.334

— From the desk

Latest News

Telix Pharmaceuticals to acquire Canadian isotope innovator ARTMS in $125.9m deal
ASX 200

Telix Pharmaceuticals to acquire Canadian isotope innovator ARTMS in $125.9m deal

Australian biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) is set to acquire Canadian radioisotope technology firm ARTMS Inc in a $125.9 million deal designed to boost its supply chain and production capacity. The deal will include ARTMS’ advanced cyclotron-based isotope production platform, a manufacturing plant and a stockpile of ultra-pure rare metals required for consumable target […]

Medibank suffers cyberattack, Telix Pharma expands GE Healthcare partnership and APA Group to acquire Basslink
ASX 200

Medibank suffers cyberattack, Telix Pharma expands GE Healthcare partnership and APA Group to acquire Basslink

Health insurance provider Medibank Private’s (ASX: MPL) shares are down this week after the company revealed it suffered a major cyber security incident. Despite the concern, the provider urged there was no evidence of customers’ data being accessed and has since returned to business as usual. Medibank has a large database, covering more than 3.7 […]

Telix withdraws Europe marketing application, AGL to close power station early and BHP prioritises Peru exploration
ASX 200

Telix withdraws Europe marketing application, AGL to close power station early and BHP prioritises Peru exploration

Telix Pharmaceuticals (ASX: TLX) has announced it has withdrawn its application to market the company’s lead prostate cancer imaging product, Illuccix, in Europe. The Danish Medicines Agency asked for additional chemistry, manufacturing and control data from Telix, but the Australian company said the requests could not be delivered within the prescribed review timeframe. Telix group […]

A2 Milk hopes to join Bubs in alleviating US infant formula crisis, ASIC sues ANZ and Telix Pharma granted pass through
ASX 200

A2 Milk hopes to join Bubs in alleviating US infant formula crisis, ASIC sues ANZ and Telix Pharma granted pass through

A2 Milk (ASX: A2M) is rallying in its efforts to join rival Bubs Australia (ASX: BUB), which revealed it will export 27.5 million bottles of infant formula products to the United States to help with a nationwide shortage created by the global pandemic. Dual-listed A2 Milk submitted an application to the US Food and Drug […]